Back to Trades
Sell4
GeneDx Holdings Corp.
WGS
Total Value
$572.2K
Net $490.9K sold
Sales
$490.9K
1 transaction
Company Information
- Company Name
- GeneDx Holdings Corp.
- Ticker Symbol
- WGS
- CIK
- 0001818331
Insider Information
- Name
- Feeley Kevin
- Role
- Insider
- Location
- STAMFORD, CT
Filing Details
- Filing Date
- Jul 11, 2025
- Transaction Date
- Jul 9, 2025
- Accession Number
- 0001415889-25-019667
- Form Type
- 4
- Net Trading Amount
- -$490.9K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jul 9, 2025 | Class A Common Stock | 1,245 | $32.67 | Exercise | $40.7K |
| Jul 9, 2025 | Class A Common Stock | 5,278 | $93.00 | Sale | $490.9K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jul 9, 2025 | Derivative | 1,245 | $32.67 | Exercise | $40.7K |
Footnotes
- (F1)The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2024.
- (F2)Following the reported sales and option exercise, in addition to the 3,392 shares of Class A common stock and the option to purchase up to 6,228 shares of Class A common stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned restricted stock units ("RSUs") representing contingent rights to receive up to an aggregate of 135,762 shares of Class A common stock and additional options to purchase up to an aggregate of 20,924 shares of Class A common stock, which RSUs and options vest according to their respective terms.
- (F3)6.25% vest in quarterly installments over the 4-year period commencing on December 1, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.